Primary outcomes
Cancer
SECONDARY, CANCER
The primary outcome was the mean change from baseline to 15 weeks (T1) after the start of treatment in HRQOL as assessed by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) (Additional information on the EORTC QLQ-C30 scales, interpretation of clinically relevant change scores, our secondary outcomes, and sensitivity analyses can be found in the 